Adeno-associated virus (AAV) based gene therapy for eye diseases
- First Online:
- 318 Downloads
Gene therapy emerged as important approach in treatment for many inborn disorders caused by genetic defects, as well as other diseases. This manuscript focused on Adeno-associated virus (AAV) based gene therapy to eye diseases. The paper firstly introduced the AAV vectors and the techniques of eye delivery, then summarized some tested genes that were used in past treatment to retinal degeneration disorders. Finally the paper discussed the updated optogenetics and its roles in AAV based gene therapy for eye diseases.
KeywordsAAV Gene therapy Optogenetics Neovascularization Trophic factor Neuroprotection
- Chong NV, Adewoyin T (2007) Intravitreal injection: balancing the risks. Eye (Lond) 21:313–316Google Scholar
- Farah N, Reutsky I, Shoham S (2007) Patterned optical activation of retinal ganglion cells. Conf Proc IEEE Eng Med Biol Soc 2007:6369–6371Google Scholar
- Schlichtenbrede FC, MacNeil A, Bainbridge JW, Tschernutter M, Thrasher AJ et al (2003b) Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration. Gene Ther 10:523–527PubMedCrossRefGoogle Scholar